Everbridge Announces Proposed Public Offering of Common Stock
Get Alerts EVBG Hot Sheet
Join SI Premium – FREE
BURLINGTON, Mass.--(BUSINESS WIRE)-- Everbridge, Inc. (Nasdaq: EVBG) today announced the launch of a proposed underwritten public offering of $125,000,000 of shares of its common stock, all of which are being offered by Everbridge. Everbridge expects to grant the underwriters a 30-day option to purchase up to an additional $18,750,000 of shares of common stock, at the public offering price, less underwriting discounts and commissions.
J.P. Morgan, BofA Merrill Lynch and Credit Suisse are acting as joint book-running managers in the offering. Stifel, KeyBanc Capital Markets, Canaccord Genuity, Needham & Company, Raymond James, SunTrust Robinson Humphrey, William Blair, and Northland Capital Markets will act as co-managers. The offering is being made pursuant to a shelf registration statement, including a base prospectus, filed by Everbridge with the Securities and Exchange Commission (SEC), which was effective upon filing. The offering may be made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC's website located at www.sec.gov. Copies of the preliminary prospectus supplement and the accompanying prospectus may also be obtained, when available, from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204, or by email at [email protected]; or from BofA Merrill Lynch NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC 28255-0001, Attn: Prospectus Department, or by email at [email protected]; or from Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, Eleven Madison Avenue, 3rd Floor, New York, NY 10010, by telephone at 1-800-221-1037, or by email at [email protected]. The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there by any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
About Everbridge
Everbridge, Inc. is a global software company that provides enterprise software applications that automate and accelerate organizations' operational response to critical events in order to keep people safe and businesses running faster. During public safety threats such as active shooter situations, terrorist attacks or severe weather conditions, as well as critical business events such as IT outages, cyber-attacks or other incidents such as product recalls or supply-chain interruptions, over 4,200 global customers rely on the companyâs SaaS-based platform to quickly and reliably aggregate and assess threat data, locate people at risk and responders able to assist, automate the execution of pre-defined communications processes, and track progress on executing response plans. The companyâs platform sent over 2.8 billion messages in 2018, and offers the ability to reach more than 200 countries and territories with secure delivery to over 100 different communication devices. The companyâs critical communications and enterprise safety applications include Mass Notification, Incident Management, Safety Connectionâ¢, IT Alerting, Visual Command Center, Crisis Commander, Community Engagement⢠and Secure Messaging. Everbridge serves 9 of the 10 largest U.S. cities, 9 of the 10 largest U.S.-based investment banks, all four of the largest global accounting firms, 25 of the 25 busiest North American airports, six of the 10 largest global consulting firms, six of the 10 largest global auto makers, all four of the largest global accounting firms, four of the 10 largest U.S.-based health care providers and four of the 10 largest U.S.-based health insurers. Everbridge is based in Boston and Los Angeles with additional offices in Lansing, San Francisco, Beijing, Bangalore, Kolkata, London, Munich, Oslo, Stockholm and Tilburg.
Forward-Looking Statements
Statements in this press release that are not strictly historical in nature, including statements related to the proposed offering by Everbridge, are âforward-looking statementsâ within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as âbelieves,â âanticipates,â âplans,â âexpects,â âintends,â âwill,â âgoal,â âpotentialâ and similar expressions are intended to identify forward-looking statements. These statements are based upon Everbridgeâs current expectations. Actual events or results could differ materially from those anticipated in such forward-looking statements due to various factors, including market risks and uncertainties and the satisfaction of customary closing conditions for an offering of securities. For a discussion of these and other factors, please refer to Everbridgeâs quarterly report on Form 10-Q for the quarter ended September 30, 2018 as well as Everbridgeâs other filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and Everbridge undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005802/en/
Investor Contact:
Garo Toomajanian
ICR
[email protected]
818-230-9712
Media Contact:
Jeff Young
Everbridge
[email protected]
781-859-4116
Source: Everbridge, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vireo Growth completes $20M Pennsylvania dispensary license deal
- EMA backs orphan drug status for Vanda's imsidolimab in rare skin disease
- AMR Resources prices $250M IPO on Nasdaq at $10 per unit
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Credit Suisse, Stifel, William Blair, JPMorgan, KeyBanc, Raymond James, Needham & Company, Canaccord Genuity, BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share